BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35611163)

  • 21. ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold.
    Yang W; Wang B; Yu Q; Liu T; Li T; Tian T; Jin A; Ding L; Chen W; Wang H; Xian J; Pan B; Zhou J; Fan J; Yang X; Guo W
    Theranostics; 2022; 12(14):6189-6206. PubMed ID: 36168627
    [No Abstract]   [Full Text] [Related]  

  • 22. OTUB2 exerts tumor-suppressive roles via STAT1-mediated CALML3 activation and increased phosphatidylserine synthesis.
    Chang W; Luo Q; Wu X; Nan Y; Zhao P; Zhang L; Luo A; Jiao W; Zhu Q; Fu Y; Liu Z
    Cell Rep; 2022 Oct; 41(4):111561. PubMed ID: 36288705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histone methyltransferase SETDB1 promotes cells proliferation and migration by interacting withTiam1 in hepatocellular carcinoma.
    Zhang Y; Huang J; Li Q; Chen K; Liang Y; Zhan Z; Ye F; Ni W; Chen L; Ding Y
    BMC Cancer; 2018 May; 18(1):539. PubMed ID: 29739365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
    Zhao X; Liu Y; Yu S
    Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CTB-193M12.5 Promotes Hepatocellular Carcinoma Progression via Enhancing NSD1-Mediated WNT10B/Wnt/β-Catenin Signaling Activation.
    Zhang S; Jiang M; Cao H; Xiong J; Xu J
    J Hepatocell Carcinoma; 2022; 9():553-569. PubMed ID: 35698644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
    Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
    J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNAAF5 promotes hepatocellular carcinoma malignant progression by recruiting USP39 to improve PFKL protein stability.
    Liu Y; Wu Q; Sun T; Huang J; Han G; Han H
    Front Oncol; 2022; 12():1032579. PubMed ID: 36276075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LINC01419 promotes cell proliferation and metastasis in hepatocellular carcinoma by enhancing NDRG1 promoter activity.
    Dang H; Chen L; Tang P; Cai X; Zhang W; Zhang R; Huang A; Tang H
    Cell Oncol (Dordr); 2020 Oct; 43(5):931-947. PubMed ID: 32557341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enabled homolog (ENAH) regulated by RNA binding protein splicing factor 3b subunit 4 (SF3B4) exacerbates the proliferation, invasion and migration of hepatocellular carcinoma cells via Notch signaling pathway.
    Deng G; Luo Y; Zhang Y; Zhang J; He Z
    Bioengineered; 2022 Feb; 13(2):2194-2206. PubMed ID: 35030977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of Gli2 stability by deubiquitinase OTUB2.
    Li XY; Mao XF; Tang XQ; Han QQ; Jiang LX; Qiu YM; Dai J; Wang YX
    Biochem Biophys Res Commun; 2018 Oct; 505(1):113-118. PubMed ID: 30241937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circular RNA circZNF566 promotes hepatocellular carcinoma progression by sponging miR-4738-3p and regulating TDO2 expression.
    Li S; Weng J; Song F; Li L; Xiao C; Yang W; Xu J
    Cell Death Dis; 2020 Jun; 11(6):452. PubMed ID: 32532962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TCF12 promotes the tumorigenesis and metastasis of hepatocellular carcinoma via upregulation of CXCR4 expression.
    Yang J; Zhang L; Jiang Z; Ge C; Zhao F; Jiang J; Tian H; Chen T; Xie H; Cui Y; Yao M; Li H; Li J
    Theranostics; 2019; 9(20):5810-5827. PubMed ID: 31534521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulation of SNX5 predicts poor prognosis and promotes hepatocellular carcinoma progression by modulating the EGFR-ERK1/2 signaling pathway.
    Zhou Q; Huang T; Jiang Z; Ge C; Chen X; Zhang L; Zhao F; Zhu M; Chen T; Cui Y; Li H; Yao M; Li J; Tian H
    Oncogene; 2020 Mar; 39(10):2140-2155. PubMed ID: 31819169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
    Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling.
    Liu J; Xu R; Mai SJ; Ma YS; Zhang MY; Cao PS; Weng NQ; Wang RQ; Cao D; Wei W; Guo RP; Zhang YJ; Xu L; Chen MS; Zhang HZ; Huang L; Fu D; Wang HY
    Theranostics; 2020; 10(17):7527-7544. PubMed ID: 32685003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RNA binding protein serine/arginine splicing factor 1 promotes the proliferation, migration and invasion of hepatocellular carcinoma by interacting with RecQ protein-like 4 mRNA.
    Ye Y; Yu F; Li Z; Xie Y; Yu X
    Bioengineered; 2021 Dec; 12(1):6144-6154. PubMed ID: 34486474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of OTUB2 suppresses colorectal cancer cell growth by regulating β-Catenin signaling.
    Xu X; Wu G; Han K; Cui X; Feng Y; Mei X; Yang P; You W; Yang Y
    Am J Cancer Res; 2023; 13(11):5382-5393. PubMed ID: 38058843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CircPAK1 promotes the progression of hepatocellular carcinoma via modulation of YAP nucleus localization by interacting with 14-3-3ζ.
    Hao X; Zhang Y; Shi X; Liu H; Zheng Z; Han G; Rong D; Zhang C; Tang W; Wang X
    J Exp Clin Cancer Res; 2022 Sep; 41(1):281. PubMed ID: 36131287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased long noncoding RNA LINC00511 is correlated with poor prognosis and contributes to cell proliferation and metastasis by modulating miR-424 in hepatocellular carcinoma.
    Wang RP; Jiang J; Jiang T; Wang Y; Chen LX
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3291-3301. PubMed ID: 31081082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
    Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
    J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.